758 related articles for article (PubMed ID: 17671216)
41. Modulation of innate immunity by IL-18.
Li W; Yamamoto H; Kubo S; Okamura H
J Reprod Immunol; 2009 Dec; 83(1-2):101-5. PubMed ID: 19853308
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
43. Increased number of suppressor T-cells and impaired IL-2 mediated T-cell function in peripheral blood of gastric cancer patients.
Tsubono M; Nio Y; Shiraishi T; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
J Clin Lab Immunol; 1990 Nov; 33(3):107-15. PubMed ID: 1966999
[TBL] [Abstract][Full Text] [Related]
44. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
45. IL-27 inhibits the development of regulatory T cells via STAT3.
Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
[TBL] [Abstract][Full Text] [Related]
46. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
47. The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.
François V; Ottaviani S; Renkvist N; Stockis J; Schuler G; Thielemans K; Colau D; Marchand M; Boon T; Lucas S; van der Bruggen P
Cancer Res; 2009 May; 69(10):4335-45. PubMed ID: 19435913
[TBL] [Abstract][Full Text] [Related]
48. Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
de León J; Fernández A; Clavell M; Labrada M; Bebelagua Y; Mesa C; Fernández LE
Int Immunol; 2008 Apr; 20(4):591-600. PubMed ID: 18310617
[TBL] [Abstract][Full Text] [Related]
49. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
50. Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma.
Zhang Y; Luo CL; He BC; Zhang JM; Cheng G; Wu XH
Int J Oncol; 2010 Jan; 36(1):133-40. PubMed ID: 19956842
[TBL] [Abstract][Full Text] [Related]
51. Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
Boyman O; Kovar M; Rubinstein MP; Surh CD; Sprent J
Science; 2006 Mar; 311(5769):1924-7. PubMed ID: 16484453
[TBL] [Abstract][Full Text] [Related]
52. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.
Khazaie K; von Boehmer H
Semin Cancer Biol; 2006 Apr; 16(2):124-36. PubMed ID: 16443370
[TBL] [Abstract][Full Text] [Related]
53. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells.
Conde P; Acosta-Saavedra LC; Goytia-Acevedo RC; Calderon-Aranda ES
Arch Toxicol; 2007 Apr; 81(4):251-9. PubMed ID: 17009048
[TBL] [Abstract][Full Text] [Related]
54. The ex vivo microenviroments in MLTC of poorly immunogenic tumor cells facilitate polarization of CD4+CD25+ regulatory T cells.
Wang Y; Zhou L; Wang HY; Xiao JX; Si LS; Wang YL
Cell Mol Immunol; 2006 Apr; 3(2):123-9. PubMed ID: 16696899
[TBL] [Abstract][Full Text] [Related]
55. Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell.
Zhao Y; Huang Z; Qi M; Lazzarini P; Mazzone T
Immunol Lett; 2007 Jan; 108(1):78-87. PubMed ID: 17161871
[TBL] [Abstract][Full Text] [Related]
56. Different forms of helper tolerance to carcinoembryonic antigen: ignorance and regulation.
Pickford WJ; Watson AJ; Barker RN
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4528-37. PubMed ID: 17671139
[TBL] [Abstract][Full Text] [Related]
57. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.
Patel SA; Meyer JR; Greco SJ; Corcoran KE; Bryan M; Rameshwar P
J Immunol; 2010 May; 184(10):5885-94. PubMed ID: 20382885
[TBL] [Abstract][Full Text] [Related]
58. Enhancing antitumor immunity: combining IL-12 with TGFbeta1 antagonism.
Fan TM; Kranz DM; Roy EJ
J Immunother; 2007; 30(5):479-89. PubMed ID: 17589288
[TBL] [Abstract][Full Text] [Related]
59. Human T cell lines and clones respond to IL-9.
Houssiau FA; Renauld JC; Stevens M; Lehmann F; Lethe B; Coulie PG; Van Snick J
J Immunol; 1993 Apr; 150(7):2634-40. PubMed ID: 8454846
[TBL] [Abstract][Full Text] [Related]
60. Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses.
Hegmans JP; Hemmes A; Hammad H; Boon L; Hoogsteden HC; Lambrecht BN
Eur Respir J; 2006 Jun; 27(6):1086-95. PubMed ID: 16540497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
